Top Markets
Coin of the day
NDT Pharmaceuticals Inc. NDT Pharmaceuticals Inc.

NDT Pharmaceuticals Inc.

NDTP
Rank in Stocks #22871
NDT Pharmaceuticals Inc., a biotechnology firm situated in Vienna, Virginia, is... NDT Pharmaceuticals Inc., a biotechnology firm situated in Vienna, Virginia, is dedicated to formulating a range of treatments for serious neurological ailments, particularly those stemming from traumatic brain injuries.
Share Price
$0.51333
Last synced: 2026-08-20
Market Cap
$82.14M
Change (1 day)
0.00%
Change (1 year)
741.52%
Country
US
Trade NDT Pharmaceuticals Inc. (NDTP)

Category

P/E ratio for NDT Pharmaceuticals Inc. (NDTP)
P/E ratio as of 2026 TTM: 0
According to NDT Pharmaceuticals Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for NDT Pharmaceuticals Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
29.20 -
US
30.62 -
NL
-7.93 -
US
32.46 -
AU
- -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.